Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
248
-
Total 13F shares, excl. options
-
24,517,182
-
Shares change
-
+1,339,191
-
Total reported value, excl. options
-
$2,627,029,783
-
Value change
-
+$143,212,248
-
Put/Call ratio
-
2.26%
-
Number of buys
-
146
-
Number of sells
-
-91
-
Price
-
$107.09
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2016
276 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q1 2016.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,517,182 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1,404,007 shares), BlackRock Fund Advisors (1,377,004 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,229,452 shares), Knott David M (1,199,766 shares), FMR LLC (975,263 shares), OAK RIDGE INVESTMENTS LLC (941,493 shares), RS INVESTMENT MANAGEMENT CO LLC (912,545 shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (839,691 shares), WELLS FARGO & COMPANY/MN (839,205 shares), and STATE STREET CORP (699,788 shares).
This table shows the top 248 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.